Louise Visit 2: A 65-year-old African-American woman with recent NSTEMI

Title:

Louise Visit 2: A 65-year-old African-American woman with recent NSTEMI
Topic: Cardiology
Relevant Terms: Acute Coronary Syndrome, Atherothrombosis, Coronary Artery Disease, Myocardial Infarction, NSTEMI, STEMI, Unstable Angina
Primary Audience: Cardiologists, Emergency Medicine Physicians, Internists, Nurse Practitioners, Physician Assistants, Primary Care Physicians
Launch Date: 03-Jun-10
Credits: 0.5 AMA PRA Category 1 Credit™
Expiration Date: 02-Jun-11

Learning Objectives

Upon completion of the activity, participants should be able to:

  1. Identify and adhere to the diagnostic criteria established by the ACC/AHA guidelines for treating ACS patients with and without comorbidity.
  2. Discuss the need to ascertain the ACS patient's risk profile for developing serious complications due to atherothrombosis.
  3. Compare the benefits and risks of current and emerging treatment options for ACS patients.

    Faculty

    Sanjay Kaul, MD, FACC, FAHA
    Director, Cedars-Sinai/VA Greater Los Angeles Cardiology Fellowship Training Program
    Director, Vascular Physiology and Thrombosis Research Laboratory
    Burns and Allen Research Institute
    Professor of Medicine
    Cedars-Sinai Medical Center
    Los Angeles, California     Duane S. Pinto, MD, MPH, FACC
    Director, Peripheral Angiographic Core Laboratory
    Director, Cardiology Fellowship Training Program
    Interventional Cardiology
    Beth Israel Deaconess Medical Center
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts     Somjot S. Brar, MD
    Director of Vascular Medicine
    Staff Interventional Cardiologist
    Kaiser Permanente Medical Center
    Los Angeles, California
    Research Scientist
    Kaiser Permanente
    Pasadena, California
    STATEMENT OF NEED
    Acute coronary syndrome (ACS) describes a spectrum of clinical symptoms causing acute myocardial ischemia ranging from unstable angina (UA) to non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI). Risks for developing ACS include lifestyle factors as well as complicating co-morbidities that the primary care physician (PCP) may not recognize, leading to delayed cardiology referral. ACS treatment trends indicate that physicians, especially PCPs, do not follow treatment guidelines recommended by the American College of Cardiology and American Heart Association (ACC/AHA), and thus are not aware of the risks and benefits of current drugs for preventing atherothrombosis in high-risk patients. Likewise, cardiac specialists do not have a thorough knowledge of the novel and emerging therapies that may help them implement best practices for their at-risk patients.

    DISCLOSURE POLICY STATEMENT
    It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.
     
    While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
    FACULTY DISCLOSURES
    Dr. Kaul has received grants, research support, honorarium, consulted for, and/or has ownership interest in Eli Lilly and Company.
     
    Dr. Brar has no real or apparent conflicts of interest to report.
     
    Dr. Pinto has received grants, research support, honorarium and/or has consulted for Daiichi Sankyo, Inc. and Lilly USA, LLC; Heartscape Technologies, Inc.; The Medicines Company; Medtronic, Inc.; Schering Plough Corp.

    PLANNERS AND REVIEWERS DISCLOSURES
    Shervin Eshaghian, MD has no real or apparent conflicts of interest to report.
    R. Michelle Tyner has no real or apparent conflicts of interest to report.
    Josh Kilbridge has no real or apparent conflicts of interest to report.

    DISCLAIMER
    The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the Cedars-Sinai Medical Center and balance ltd. The information is presented for the purpose of advancing the attendees' professional development.

    CREDIT DESIGNATION
    Cedars-Sinai Medical Center designates this educational activity for a maximum of up to 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ACCREDITATION STATEMENT
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cedars-Sinai Medical Center and balance ltd. Cedars-Sinai Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 0.5 AMA PRA Category 1 Credit™. Statement of credit will be available to print from your user history page.
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    COURSE FORMAT: Internet CME Activity

    COURSE VIEWING REQUIREMENTS
    PC: Internet Explorer (v6 or greater), or Firefox
    MAC: Safari

    Release Date:     June 3, 2010
    Expiration Date: June 2, 2011
    Estimated Time to Complete:     30 minutes

    COMMERCIAL SUPPORT
    Supported by educational grants from Bristol-Myers Squibb, Pfizer Inc., Daiichi Sankyo, Inc. and Lilly USA, LLC.

    Jointly sponsored by Cedars-Sinai Medical Center and balance ltd.

    Cedars-Sinai Medical Center Privacy Policy
    http://www.cedars-sinai.edu/5237.html

    Cedars-Sinai Medical Center Terms and Conditions
    http://www.cedars-sinai.edu/5238.html

    ©2010 Cedars-Sinai Medical Center and balance ltd.